|
| Status |
Public on Jul 01, 2024 |
| Title |
Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis |
| Organisms |
Homo sapiens; Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
Other
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Contributor(s) |
Amrute JM, Luo X, Yamawaki T, Li C, Ason B, Lavine KJ |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| |
| Submission date |
Nov 20, 2022 |
| Last update date |
Jul 01, 2024 |
| Contact name |
Xin Luo |
| E-mail(s) |
xluo01@amgen.com
|
| Organization name |
Amgen Inc
|
| Department |
Research and Development
|
| Street address |
750 Gateway Blvd
|
| City |
South San Francisco |
| State/province |
CA |
| ZIP/Postal code |
94080 |
| Country |
USA |
| |
|
| Platforms (2) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (120)
|
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE217494 |
Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis I |
| GSE218391 |
Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis II |
| GSE270788 |
Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis III |
| GSE270875 |
Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis IV |
| GSE270904 |
Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis V |
| GSE270961 |
Targeting Immune-Fibroblast Crosstalk in Myocardial Infarction and Cardiac Fibrosis VI |
|
| Relations |
| BioProject |
PRJNA903478 |
Less...
More...